Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

The government agency says X no longer suits its communication needs.

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol ...

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.